Dynavax Technologies Corp. (DVAX)
15.50
+0.01
(+0.06%)
USD |
NASDAQ |
Feb 06, 16:00
15.49
-0.01
(-0.06%)
After-Hours: 20:00
Dynavax Technologies SG&A Expense (TTM) : 179.71M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Merck & Co., Inc. | 10.73B |
| Amicus Therapeutics, Inc. | 353.07M |
| Agios Pharmaceuticals, Inc. | 180.37M |
| Hyperion DeFi, Inc. | 15.85M |
| Edgewise Therapeutics, Inc. | 36.80M |